Nimbus Therapeutics

Nimbus Therapeutics

Nimbus Therapeutics

Biotech company harnessing the power of computational chemistry to design breakthroughs for serious, underserved diseases.
Type
B2c
Founded
2009
Raised
$89M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$65,000,000
Venture capital (Series C) - 2018
Atlas Venture SR One Lilly Ventures +4
$24,000,000
Venture capital (Series A) - 2011
Team Size
1–10
Employees
$65,000,000 Venture capital (Series C)
FinSMEs , PE HUB

Biotech Company Nimbus Therapeutics Secures $65M in Funding

Funding